Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves Bureau

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
The Psychiatric Clinics of North America|December 3, 2014
The role of nutrient-based epigenetic changes in buffering against stress, aging, and Alzheimer's diseaseSimon Chiu, Michel A Woodbury-Fariña, Mujeeb U Shad, et al.
Thyroid : Official Journal of the American Thyroid Association|September 17, 2019
Risk for Thyroid Cancer Recurrence Is Higher in Men Than in Women Independent of Disease Stage at PresentationAfshan Zahedi, Louis Bondaz, Murali Rajaraman, et al.
British Journal of Pharmacology|January 28, 2004
Neuroprotective effects of M826, a reversible caspase-3 inhibitor, in the rat malonate model of Huntington's diseaseSylvie Toulmond, Keith Tang, Yves Bureau, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
The Psychiatric Clinics of North America|December 3, 2014
The role of nutrient-based epigenetic changes in buffering against stress, aging, and Alzheimer's diseaseSimon Chiu, Michel A Woodbury-Fariña, Mujeeb U Shad, et al.
Thyroid : Official Journal of the American Thyroid Association|September 17, 2019
Risk for Thyroid Cancer Recurrence Is Higher in Men Than in Women Independent of Disease Stage at PresentationAfshan Zahedi, Louis Bondaz, Murali Rajaraman, et al.
British Journal of Pharmacology|January 28, 2004
Neuroprotective effects of M826, a reversible caspase-3 inhibitor, in the rat malonate model of Huntington's diseaseSylvie Toulmond, Keith Tang, Yves Bureau, et al.
Pageof 6